ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: Madrigal Pharmaceuticals, Inc. (MDGL) Report Updated: Jan 13, 2018 | Print This Page

Get more stock ratings by Louis Navellier

Madrigal Pharmaceuticals, Inc. (MDGL)

Rating: Strong Buy Volatility: Aggressive
Total Grade: A Industry: Pharmaceuticals: Other
Competitors: CYAD,MYOK,ASMB,XENT

Stock Analysis

Rating: Monthly View

A
B
C
D
F
January February March April May June July August September October November December

Rating: Weekly View

This Week: A down no change
Last Week: A same no change
Two Weeks Ago: A up no change
service keys

Madrigal Pharmaceuticals, Inc.© quotemedia

Company Profile